Acute Migraine Treatment Gets a New Drug

(MedPage Today) -- The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or without aura, Axsome Therapeutics announced.
Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory...